Cat.#: ACPP-1333
| Despition | Nurr1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
| ACPP-1578 | Human QPCT Protein (AC1578) | 2 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1070 | Human Neuron Specific Enolase (Active) (AC1070) | 100 µg | inquiry |
| ACPP-1052 | Recombinant Human PGRPS Protein (Fc Tag) (AC1052) | 50 µg | inquiry |
| ACPP-1653 | Human CRYM Protein (AC1653) | 2 µg | inquiry |
| ACPP-1225 | POMT1 Blocking Peptide (AC1225) | 250 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
| ACPP-1267 | Acrp30 Mouse, Trimeric (AC1267) | 2 µg | inquiry |
| ACPP-1570 | Human Acrp30 Protein, Trimeric (AC1570) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.